EyeGate Pharmaceuticals, Inc. (EYEG) Starts Presentation at Marcum MicroCap Conference

EyeGate Pharma (NASDAQ: EYEG) is a late-stage specialty pharmaceutical company focused on developing and commercializing therapeutics and drug delivery mechanisms for treating diseases of the eye. The company’s technology addresses two of the most prevalent issues in ophthalmic care: the existing lack of patient adherence, and patient safety. EyeGate Pharma is committed to advancing its delivery technology and therapeutic candidates with a goal of bringing new, potentially superior treatment options to patients who will most likely benefit. For more information, visit the company’s website at www.eyegatepharma.com